The Long-Term Tolerability and Efficacy of Armodafinil in Patients with Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy: An Open-Label Extension Study

STUDY OBJECTIVES: Armodafinil is a wakefulness-promoting medication. Its efficacy and tolerability have been established in 12-week studies of patients with excessive sleepiness (ES) associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. This study evaluated...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Black, Jed E., Hull, Steven G., Tiller, Jane, Yang, Ronghua, Harsh, John R.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Academy of Sleep Medicine 2010
נושאים:
New Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952749/
https://ncbi.nlm.nih.gov/pubmed/20957846
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים